pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·May 7·1 min read
save

Health insurers grapple with profit cuts after a costly 2025, outlook for 2026 remains uncertain

May 7, 2026·read at Endpoints ↗Negative

In 2025, a wave of health insurers reduced or withdrew their profit forecasts after being hit by rising medical expenses.

The cost pressures stemmed from higher drug prices, increased utilization of services, and inflationary trends that squeezed margins across the industry.

While some analysts note that 2026 may bring modest improvement as insurers adjust pricing and cost-management strategies, the overall environment remains challenging and uncertainty persists.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Are health insurers out of the woods after a tough 2025?”

read at Endpoints ↗
74 words · retrieved May 7
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
RISING

related stories

  • May 13Officials say $1.3 billion in Medicaid money to California will be deferred over suspicions of fraudSTAT
  • May 13U.S. overdose deaths fell again in 2025, but some worry about policy and drug supply changesSTAT
  • May 13The ‘velocity of obesity’ aims to show which nations are slowing an epidemicSTAT
  • May 13Extreme heat is worsening faster for Black AmericansSTAT
  • May 13STAT+: A new kind of liver crisis is emerging in the U.S. The American diet is to blameSTAT